Expression of vascular endothelial growth factor and transforming growth factor alpha in rat testis during chronic renal failure

Introduction. Vascular endothelial growth factor (VEGF) is known to influence testis function. Transforming growth factor alpha (TGF-α) is expressed in the postnatal testis, and has been demonstrated to stimulate testis development. Systemic diseases such as chronic renal failure (CRF) interfere with hypothalamic-pituitary-go­nadal axis, which may cause defective steroidogenesis and gonadal functions. The aim of this study was to inve­stigate the expression and localization of VEGF and TGF-α in testicular tissues of experimental CRF model. Material and methods. Experimental CRF was induced in rats by the resection of more than 85% of renal mass. The expression of VEGF and TGF-α in testicular tissues were assessed by immunohistochemistry on paraffin sections of control, CRF-nondialysed and CRF-dialysed rats. Results. The microscopic evaluation of the testicular structure showed that CRF did not affect testicular histology. Immunohistochemical evaluation showed that VEGF was expressed in the cytoplasm of primary and secondary spermatocyte series as well as the early spermatids. Staining intensity was lower in sperma­tocytes going through the first meiotic division. TGF-α was expressed in the nuclei of spermatogonia and primary spermatocytes with stronger staining intensity in spermatogonia. The intensity of VEGF staining was similar in control and experimental animals, however, TGF-α expression was lower in the CRF group.Conclusions. The continuous expression of VEGF in spermatocytes and spermatids suggests that the applied model of CRF does not directly disrupt morphology of seminiferous epithelium, thus also spermiogenesis. However, difference between control rats and CRF group in TGF-α immunopositivity, which was localised in spermatogonial mitosis step, may suggest the interference of CRF with early stages of spermatogenesis.

The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.

Parkinson's disease (PD) is the second most common neurodegenerative disorder marked by cell death in the Substantia nigra (SN). Docosahexaenoic acid (DHA) is the major polyunsaturated fatty acid (PUFA) in the phospholipid fraction of the brain and is required for normal cellular function. Glial cell line derived neurotrophic factor (GDNF) and neurturin (NTN) are very potent trophic factors for PD. The aim of the study was to evaluate the neuroprotective effects of GDNF and NTN by investigating their immunostaining levels after administration of DHA in a model of PD. For this reason we hypothesized that DHA administration of PD might alter GDNF, NTN expression in SN. MPTP neurotoxin that induces dopaminergic neurodegeneration was used to create the experimental Parkinsonism model. Rats were divided into; control, DHA-treated (DHA), MPTP-induced (MPTP), MPTP-induced+DHA-treated (MPTP+DHA) groups. Dopaminergic neuron numbers were clearly decreased in MPTP, but showed an increase in MPTP+DHA group. As a result of this, DHA administration protected dopaminergic neurons as shown by tyrosine hydroxylase immunohistochemistry. In the MPTP+DHA group, GDNF, NTN immunoreactions in dopaminergic neurons were higher than that of the MPTP group. In conclusion, the characterization of GDNF and NTN will certainly help elucidate the mechanism of DHA action, and lead to better strategies for the use of DHA to treat neurodegenerative diseases

One-year follow-up evaluation of radiological and respiratory findings and functional capacity in COVID-19 survivors without comorbidities

The aim of this study was to assess clinical findings, radiological data, pulmonary functions and physical capacity change over time and to investigate factors associated with radiological abnormalities after coronavirus disease 2019 (COVID-19) in non-comorbid patients. This prospective cohort study was conducted between April 2020 and June 2020. A total of 62 symptomatic in non-comorbid patients with COVID-19 pneumonia were included in the study. At baseline and the 2nd, 5th and 12th months, patients were scheduled for follow-up. Males represented 51.6% of the participants and overall mean age was 51.60 ± 12.45 years. The percentage of patients with radiological abnormalities at 2 months was significantly higher than at 5 months (P < .001). At 12 months, dyspnea frequency (P = .008), 6-minute walk test (6MWT) distance (P = .045), BORG-dyspnea (P < .001) and BORG-fatigue (P < .001) scores was significantly lower, while median SpO2 after 6MWT (P < .001) was significantly higher compared to results at 2 months. The presence of radiological abnormalities at 2 months was associated with the following values measured at 5 months: advanced age (P = .006), lung involvement at baseline (P = .046), low forced expiratory volume in 1 second (P = .018) and low forced vital capacity (P = .006). Even in COVID-19 patients without comorbidities, control computed tomography at 2 months and pulmonary rehabilitation may be beneficial, especially in COVID-19 patients with advanced age and greater baseline lung involvement

Military tuberculosis and tuberculous meningitis occuring following cuboidal osteomyelitis due to tuberculosis: Case report

Tüberküloz (tbc) dünyada en yaygın infeksiyonlardan biridir. Akciğer dışı organ ve doku tüberkülozlarına ekstrapulmoner tbc adı verilir. Ekstrapulmoner tutulum tüm tbc olgularının yaklaşık % 20'sinde görülmektedir. Bu yazıda, küboid kemikteki tüberküloza sekonder olarak tbc meninjit ve miliyer tbc gelişen 25 yaşında bir erkek olgu sunulmuştur. Literatürde tüberküloza bağlı meninjit.ve kraniyal kemik osteomyeliti birlikteliği bildirilmiştir, ancak ekstrakraniyal kemik ostemyeliti ve tbc meninjit ile miliyer tbc birlikteliğine rastlanmamıştır. Bu olgu; aynı anda tüberküloza bağlı birden çok organ tutulumu görülmesi nedeniyle yayınlanmaya değer bulunmuştur.Tuberculosis is one of the most common infectious diseases in the world. Tuberculosis that involves organs and tissues other than lungs is named as extrapulmoner tuberculosis. Extrapulmonary involvement is seen in about 20% of all tuberculosis cases. In this report, a 25-year-old male with miliary tbc and tbc meningitis occuring following cuboidal osteomyelitis due to tuberculosis is presented. In the literature some cases are presented with tbc meningitis and cranial osteomyelitis that occur together, but there has been no case with concurrent extracranial tbc osteomyelitis and tbc meningitis. This case is presented because of tuberculous multiorgan involvement

An Electrophysiological Study of Peripheral Polyneuropathy in Brucellosis

Background: Brucellosis is an anthropozoonotic disease with heterogeneous clinical presentations. This study aims to investigate the peripheral nervous system (PNS) involvement in brucellosis